OXAYDO Trademark

Trademark Overview


On Thursday, November 27, 2014, a trademark application was filed for OXAYDO with the United States Patent and Trademark Office. The USPTO has given the OXAYDO trademark a serial number of 86466673. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, February 17, 2021. This trademark is owned by Acura Pharmaceuticals, Inc.. The OXAYDO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, immediate-release oxycodone hydrochloride for pain relief in tablet form
oxaydo

General Information


Serial Number86466673
Word MarkOXAYDO
Filing DateThursday, November 27, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, February 17, 2021
Registration Number4847742
Registration DateTuesday, November 3, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 2, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, immediate-release oxycodone hydrochloride for pain relief in tablet form

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 5, 2014
Primary Code005
First Use Anywhere DateWednesday, September 9, 2015
First Use In Commerce DateWednesday, September 9, 2015

Trademark Owner History


Party NameAcura Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPalatine, IL 60067

Party NameAcura Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPalatine, IL 60067

Party NameAcura Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalatine, IL 60067

Trademark Events


Event DateEvent Description
Friday, December 5, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 20, 2015EXAMINERS AMENDMENT -WRITTEN
Monday, December 1, 2014NEW APPLICATION ENTERED
Monday, March 16, 2015ASSIGNED TO EXAMINER
Friday, March 20, 2015EXAMINERS AMENDMENT E-MAILED
Friday, March 20, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 20, 2015EXAMINER'S AMENDMENT ENTERED
Saturday, April 25, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 2, 2015PUBLISHED FOR OPPOSITION
Tuesday, June 2, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 28, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 1, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 25, 2015ASSIGNED TO LIE
Wednesday, May 13, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 3, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, November 9, 2020TEAS SECTION 8 & 15 RECEIVED
Wednesday, February 17, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 18, 2015TEAS STATEMENT OF USE RECEIVED
Friday, September 18, 2015USE AMENDMENT FILED
Thursday, September 24, 2015STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 24, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 25, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, September 26, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 3, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, February 17, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, November 3, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, September 22, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 22, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 22, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 17, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.